Back to search

Switzerland· 54766003

Recormon PS 4000 U.I./0,3 mL, Fertigspritzen

A erythropoietin product containing epoetinum beta, registered in Switzerland by Roche Pharma (Schweiz) AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC B03XA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRecormon PS 4000 U.I./0,3 mL, Fertigs…ATCB03XA01REGISTER NO.54766003PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Erythropoietin is registered in 12 of 19 countries.

Countries holding a registration under ATC B03XA01 (erythropoietin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Erythropoietin · ATC B03XA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
epoetinum beta
Manufacturer
Roche Pharma (Schweiz) AG
Country
Switzerland (CH)
ATC code
B03XA01
ATC class
Erythropoietin
Defined daily dose
1 TSD, E
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680547660030
    Fertspr 6 Stk
    CHF 200.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for erythropoietin.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erythropoietin · interactions on record

18 records

  • 5 severe
  • 3 moderate
  • 10 minor

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • ThalidomideL04AX02severe
  • LenalidomideL04AX04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythropoietin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythropoietin products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Erypo
  • Belgium · Eprex
  • Czechia · Eprex
  • Germany · Erypo Fs
  • Spain · Eprex
  • France · Eprex
  • United Kingdom (Northern Ireland) · Eprex
  • Greece · Eprex
  • Iceland · Abseamed, Binocrit
  • Italy · Eprex
  • Liechtenstein · Binocrit, Epoetin Alfa Hexal
  • Luxembourg · Eprex
  • Netherlands · Eprex
  • Norway · Abseamed, Binocrit
  • Portugal · Eprex
  • Slovenia · Eprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e61b2ba4-817b-4f03-9c24-4ba98fd4ebb9
GET /v1/drugs/e61b2ba4-817b-4f03-9c24-4ba98fd4ebb9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "epoetinum beta adnr 4000 UI",
  "valid_from": "2019-11-01",
  "limitations": "[{\"description\":\"<b>Renale Anämie bei Niereninsuffizienz.</b><br> \\n<br>\\nBehandlung der symptomatischen Anämie (Hb < 10,5 g/dl) bei erwachsenen Patienten mit nicht-myeloiden malignen Erkrankungen unter Chemotherapie, die eine Anämie verursachen können.\\n<br>\\nBehandlung der Anämie (Hb < 10 g/dl) bei erwachsenen Patienten mit multiplem Myelom, niedrig-malignem Non-Hodgkin-Lymphom oder chronischer lymphatischer Leukämie, die einen relativen Erythropoietinmangel aufweisen und eine antitumorale Therapie erhalten.\\n<br>\\nVor Wahleingriffen zur Ermöglichung von Eigenblutspenden bei anämischen Patienten, die aus immunologischen Gründen kein Fremdblut tolerieren.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-12-01\"}]",
  "galenic_form": "Inj Lös 4000 IE/0.3ml +Nadel",
  "therapeutic_area": null,
  "sl_inclusion_date": "2002-01-01",
  "self_retention_pct": 10
}

See everything about erythropoietin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.